| abstract |
The invention provides a pharmaceutical composition having excellent anti-osteoporosis activity, anti-inflammation activity, anti-rheumatoid arthritis activity and anti-hypercalcemia activity. Preferred are compositions comprising a compound of Formula (I') or a pharmacologically acceptable salt thereof as an active ingredient: (see formula I') wherein: R5 and R6 each independently represent a substituent on a benzene ring, the substituent being selected from substituent group a; R7 represents a hydrogen atom, a C1-C6 haloalkyl group, a C1-C6 hydroxyalkyl group which may be protected by a hydroxyl protecting group, a C1-alkyl group which may be substituted with one group or more than one group selected from substituent group .beta., a C6-C10 aryl group which may be substituted with one group or more than one group selected from substituent group a, or a C3-cycloalkyl group which may be substituted with one group or more than one group selected from substituent group .alpha.; m represents an integer of 1 to 3; n represents an integer of 1 to 3; and the numerals on each benzene ring represent the position number of each substitution. |